Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

SELL
$0.08 - $21.0 $17,854 - $4.69 Million
-223,182 Reduced 52.38%
202,937 $12,000
Q2 2022

Aug 09, 2022

BUY
$0.16 - $0.47 $68,179 - $200,275
426,119 New
426,119 $72,000
Q1 2022

May 17, 2022

SELL
$0.42 - $0.62 $52,132 - $76,956
-124,124 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$0.56 - $1.71 $69,509 - $212,252
124,124 New
124,124 $71,000
Q3 2021

Nov 12, 2021

SELL
$1.21 - $1.8 $13,492 - $20,071
-11,151 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$1.56 - $1.98 $17,395 - $22,078
11,151 New
11,151 $19,000
Q2 2020

Aug 07, 2020

SELL
$0.47 - $0.72 $7,924 - $12,139
-16,860 Closed
0 $0
Q4 2019

Feb 04, 2020

SELL
$0.35 - $0.58 $4,558 - $7,554
-13,025 Reduced 43.58%
16,860 $10,000
Q3 2019

Nov 20, 2019

SELL
$0.38 - $0.52 $710 - $972
-1,870 Reduced 5.89%
29,885 $15,000
Q2 2019

Aug 13, 2019

BUY
$0.39 - $0.7 $4,721 - $8,474
12,107 Added 61.62%
31,755 $12,000
Q1 2019

Apr 12, 2019

BUY
$0.43 - $0.68 $8,448 - $13,360
19,648 New
19,648 $11,000
Q4 2018

Jan 16, 2019

SELL
$0.39 - $0.7 $8,299 - $14,896
-21,281 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$0.44 - $3.02 $9,363 - $64,268
21,281 New
21,281 $11,000
Q1 2018

May 14, 2018

SELL
$2.16 - $3.48 $199,463 - $321,357
-92,344 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$0.68 - $4.19 $55,718 - $343,324
81,939 Added 787.5%
92,344 $376,000
Q3 2017

Nov 15, 2017

BUY
$0.38 - $0.66 $3,953 - $6,867
10,405
10,405 $0

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Market Cap $2.26M
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.